Skip to main content
Erschienen in: Annals of Nuclear Medicine 2/2015

01.02.2015 | Original Article

Cardiac blood pool activity on postablation radioiodine imaging

verfasst von: Ayşe Aktaş, Beyza Kocabaş, Seval Erhamamcı, Arzu Gençoğlu, Cevdet Liman

Erschienen in: Annals of Nuclear Medicine | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

There are reports on physiologic and pathologic mediastinal uptake on radioiodine imaging in patients with thyroid carcinoma. The most commonly reported physiologic causes of mediastinal uptake are esophageal retention of salivary secretion and uptake by hyperplastic or normal thymus gland. In this study, we evaluated physiologic cardiac blood pool (CBP) activity and its associated findings on radioiodine imaging.

Methods

Cardiac blood pool activity was evaluated in 186 postablation and 32 posttherapy scans. After oral radioiodine administration, imaging was initiated on day 7. Thyroglobulin, anti-thyroglobulin and TSH blood level determination was carried out in all patients. Whole-body scans were inspected with regard to residual thyroid uptake, esophageal uptake, CBP activity, hepatic activity and metastatic iodine uptake. Uptake in the residual thyroid tissue was graded visually as mild (m), moderate (M) and significant (S). Whenever CBP activity was detected on visual inspection, its intensity was graded as mild (1), moderate (2), and significant (3).

Results

Cardiac blood pool activity was detected in 61 postablation scans (33 %). Residual thyroid uptake was observed in all patients with CBP. A significant correlation existed between the intensity of uptake and the presence of CBP (p < 0.05). The mean Tg in patients with CBP was significantly higher than those without CBP (p < 0.05). Cardiac blood pool activity was not observed in any posttherapy scans and in those scans with distant metastases in the postablation group. Linear or irregular activity pattern thought to be due to esophagus was detected in 4 % of postablation scans.

Conclusions

The results have revealed CBP to be common on postablation scans. Its presence correlated with the intensity of residual thyroid uptake and had a significant association with increased thyroglobulin levels. Its absence on posttherapy scans despite increased Tg levels suggested that this activity is due to labeled thyroid hormones released by the residual thyroid tissue. Its presence might imply a high level of blood radiation dose.
Literatur
1.
Zurück zum Zitat Bakheet SM, Powe J, Hammami MM. Radioiodine uptake in the chest. J Nucl Med. 1997;38:984–6.PubMed Bakheet SM, Powe J, Hammami MM. Radioiodine uptake in the chest. J Nucl Med. 1997;38:984–6.PubMed
2.
Zurück zum Zitat Wilson LM, Barrington SF, Morrison ID, Kettle AG, O’Doherty MJ, Coakley AJ. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med. 1998;25:622–8.CrossRefPubMed Wilson LM, Barrington SF, Morrison ID, Kettle AG, O’Doherty MJ, Coakley AJ. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med. 1998;25:622–8.CrossRefPubMed
3.
Zurück zum Zitat Ziessman HA, Bahar H, Fahey FH, Dubiansky V. Hepatic visualization of Iodine-131 whole-body thyroid cancer scans. J Nucl Med. 1987;28:1408–11.PubMed Ziessman HA, Bahar H, Fahey FH, Dubiansky V. Hepatic visualization of Iodine-131 whole-body thyroid cancer scans. J Nucl Med. 1987;28:1408–11.PubMed
4.
Zurück zum Zitat Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC, Cho BY, et al. Clinical significance of hepatic visualization on Iodine-131 whole-body scan in patients with thyroid carcinoma. J Nucl Med. 1997;38:1191–5.PubMed Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC, Cho BY, et al. Clinical significance of hepatic visualization on Iodine-131 whole-body scan in patients with thyroid carcinoma. J Nucl Med. 1997;38:1191–5.PubMed
5.
Zurück zum Zitat Myant NB. Early effects of radioiodine on human thyroid function. Clin Sci. 1953;12:235–45.PubMed Myant NB. Early effects of radioiodine on human thyroid function. Clin Sci. 1953;12:235–45.PubMed
6.
Zurück zum Zitat Hammersley PAG, Al-saadi A, Chittenden S, Flux GD, McCready VR, Harmer CL. Value of protein-bound radioactive iodine measurements in the management of differentiated thyroid cancer treated with I-131. Br J Radiol. 2001;74:429–33.CrossRefPubMed Hammersley PAG, Al-saadi A, Chittenden S, Flux GD, McCready VR, Harmer CL. Value of protein-bound radioactive iodine measurements in the management of differentiated thyroid cancer treated with I-131. Br J Radiol. 2001;74:429–33.CrossRefPubMed
7.
Zurück zum Zitat Hanscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, et al. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rTSH and hormone withdrawal. J Nucl Med. 2006;47:648–54.PubMed Hanscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, et al. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rTSH and hormone withdrawal. J Nucl Med. 2006;47:648–54.PubMed
8.
Zurück zum Zitat Verburg FA, Lassmannn M, Mader U, Luster M, Reiners C, Hanscheid H. The absorbed dose to the blood is a better predictor of ablation success than the administered I-131 activity in thyroid cancer patients. Eur J Nucl Med. 2011;38:673–80.CrossRef Verburg FA, Lassmannn M, Mader U, Luster M, Reiners C, Hanscheid H. The absorbed dose to the blood is a better predictor of ablation success than the administered I-131 activity in thyroid cancer patients. Eur J Nucl Med. 2011;38:673–80.CrossRef
9.
Zurück zum Zitat Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med. 1999;26:1448–52.CrossRefPubMed Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med. 1999;26:1448–52.CrossRefPubMed
10.
Zurück zum Zitat Jong-Ryool Oh, Ahn Byeong-Cheol. False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. Am J Nucl Med Mol Imaging. 2012;2:362–85. Jong-Ryool Oh, Ahn Byeong-Cheol. False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. Am J Nucl Med Mol Imaging. 2012;2:362–85.
Metadaten
Titel
Cardiac blood pool activity on postablation radioiodine imaging
verfasst von
Ayşe Aktaş
Beyza Kocabaş
Seval Erhamamcı
Arzu Gençoğlu
Cevdet Liman
Publikationsdatum
01.02.2015
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 2/2015
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-014-0925-7

Weitere Artikel der Ausgabe 2/2015

Annals of Nuclear Medicine 2/2015 Zur Ausgabe

Acknowledgements to Reviewers

Acknowledgements to Reviewers